A new study by researchers at Wake Forest University School of Medicine and Vanderbilt University suggests that protecting infants from a common, highly contagious and even deadly disease may be as easy as administering a routine vaccine two weeks earlier than it is typically given.
This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases.
Hib, a bacterium that can cause deadly meningitis and pneumonia, is one of the top killers of young children in the developing world. Even with treatment, an estimated 23,000 children die of Hib disease in Pakistan every year. Survivors are often permanently disabled—paralyzed, deafened or brain damaged. Globally, over 1,000 children under 5 years of age die from Hib-related diseases each day.
Recent advances in cervical cancer prevention mean that controlling the disease in developing countries is becoming feasible for the first time, experts say.
Recent advances in cervical cancer prevention mean that controlling the disease in developing countries is becoming feasible for the first time, experts say.
A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today.
Sharyl Attkisson Investigates Vaccine Advocates Taking Funding From The Companies Whose Vaccines They Endorse
(CBS) For years some parents and scientists have raised concerns about vaccine safety, including a possible link to autism and ADD. Many independent experts have sided with government officials and other scientists who say there's no possible connection. But how "independent" are they? CBS News investigative correspondent Sharyl Attkisson shares here's what she found.
Researchers have developed a plant-based cancer vaccine tailored to a patient's specific tumour type and capable of kick-starting the body's immune response, according to a study issued yesterday.
While they have not yet determined whether the immune response is sufficient to destroy the cancer, the researchers are hopeful the technique could one day lead to a cure for at least some types of the deadly disease.
Senior author Ronald Levy, of the Stanford University Medical Centre, said, ''The idea is to marshal the body's own immune system to fight cancer.''
Tomatoes could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to a study published in the Biotechnology Letters.
HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) in Korea and colleagues from Digital Biotech Inc. and the Department of Biological Science at Wonkwang University conducted the study.
The researchers reported that mice fed tomatoes with a beta-amyloid protein developed immune response to the foreign protein.
he World Health Organization Initiative for Vaccine Research recently convened a panel of TB vaccine trial experts to examine the best way of testing immunity in blood taken from people vaccinated with a new TB vaccine.